E. Ralfkiaer

2.0k total citations · 1 hit paper
15 papers, 1.4k citations indexed

About

E. Ralfkiaer is a scholar working on Pathology and Forensic Medicine, Dermatology and Immunology. According to data from OpenAlex, E. Ralfkiaer has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 6 papers in Dermatology and 6 papers in Immunology. Recurrent topics in E. Ralfkiaer's work include Lymphoma Diagnosis and Treatment (10 papers), Cutaneous lymphoproliferative disorders research (6 papers) and T-cell and Retrovirus Studies (5 papers). E. Ralfkiaer is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Cutaneous lymphoproliferative disorders research (6 papers) and T-cell and Retrovirus Studies (5 papers). E. Ralfkiaer collaborates with scholars based in Denmark, United Kingdom and France. E. Ralfkiaer's co-authors include Rein Willemze, Emilio Berti, Wolfram Sterry, Chris J.L.M. Meijer, M. Goos, Marco Santucci, Maria Sole Chimenti, J.L. Díaz-Pérez, Robert Knobler and Neil Smith and has published in prestigious journals such as Blood, PLoS ONE and American Journal of Ophthalmology.

In The Last Decade

E. Ralfkiaer

15 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.

1997 949 citations Rein Willemze, H. Kerl et al. Blood profile →

Peers

Countries citing papers authored by E. Ralfkiaer

Since Specialization

Citations

This map shows the geographic impact of E. Ralfkiaer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Ralfkiaer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Ralfkiaer more than expected).

Fields of papers citing papers by E. Ralfkiaer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Ralfkiaer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Ralfkiaer. The network helps show where E. Ralfkiaer may publish in the future.

Co-authorship network of co-authors of E. Ralfkiaer

This figure shows the co-authorship network connecting the top 25 collaborators of E. Ralfkiaer. A scholar is included among the top collaborators of E. Ralfkiaer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Ralfkiaer. E. Ralfkiaer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Development and Blind Clinical Validation of a MicroRNA Based Predictor of Response to Treatment with R-CHO(E)P in DLBCL 2015 ·PLoS ONE ·Steen Knudsen, Christoffer Hother, Kirsten Grønbæk, Thomas E. Jensen, (unknown), Wiktor Mazin, Jesper Dahlgaard, Michael Møller, E. Ralfkiaer, Peter de Nully Brown	20
2	The importance of Notch signaling in peripheral T-cell lymphomas 2013 ·Leukemia & lymphoma ·Maria R. Kamstrup, Edyta Biskup, Lise Mette Rahbek Gjerdrum, E. Ralfkiaer, (unknown), Robert Gniadecki	13
3	Upfront Autologuos Stem Cell Transplantation in Peripheral T-cell Lymphoma (NLG-T-01) 2012 ·Francesco d’Amore, Thomas Relander, Grete F. Lauritzsen, Esa Jantunen, H Hagberg, Henry A. Anderson, Harald Holte, Anders Österborg, Mats Merup, Peter de Nully Brown, Outi Kuittinen, Martin Erlanson, Bjørn Østenstad, (unknown), Ole Gadeberg, Christer Sundström, Jan Delabie, E. Ralfkiaer, Martine Vornanen, Helle Toldbod	1
4	Dose-dense induction followed by autologous stem cell transplant (ASCT) leads to sustained remissions in a large fraction of patients with previously untreated peripheral t-cell lymphomas (PTCLS) - overall and subtype-specific results of a phase II study from the nordic lymphoma group 2009 ·Lund University Publications (Lund University) ·Francesco d’Amore, Thomas Relander, (unknown), Esa Jantunen, H Hagberg, Harald Anderson, Eva Cavallin‐Ståhl, Harald Holte, Anders Österborg, Mats Merup, Patrick A. Brown, Outi Kuittinen, Martin Erlanson, (unknown), Ole Gadeberg, Christer Sundström, Jan Delabie, E. Ralfkiaer, Martine Vornanen, (unknown)	20
5	FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival 2007 ·Leukemia ·Lise Mette Rahbek Gjerdrum, Anders Woetmann, Niels Ødum, Christopher M. Burton, Kristian Rossen, Gunhild Lange Skovgaard, Lars P. Ryder, E. Ralfkiaer	119
6	Cancer genomics 2007 ·Apmis ·(unknown), (unknown), E. Ralfkiaer	1
7	Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force study 2006 ·American Journal of Ophthalmology ·Lene Dissing Sjø, E. Ralfkiaer, Birgitte Ravn Juhl, Jan Ulrik Prause, Tero Kivelä, Claudia Auw‐Haedrich, F Bacin, (unknown), Sarah E. Coupland, B. Delbosc, N Ducrey, B Kantelip, (unknown), Paul N. Meyer, Nicolai Christian Sjö, Steffen Heegaard	6
8	Primary gastrointestinal non‐Hodgkin's lymphoma in adults: a population‐based clinical and histopathologic study 1998 ·Journal of Internal Medicine ·(unknown), (unknown), (unknown), Ulrik Pedersen‐Bjergaard, (unknown), E. Ralfkiaer	17
9	EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. breakdown → 1997 ·Blood ·Rein Willemze, H. Kerl, Wolfram Sterry, Emilio Berti, Lorenzo Cerroni, Maria Sole Chimenti, J.L. Díaz-Pérez, (unknown), M. Goos, Robert Knobler, E. Ralfkiaer, Marco Santucci, Neil Smith, Janine Wechsler, W.A. van Vloten, Chris J.L.M. Meijer	949
10	AN IMMUNOHISTOCHEMICAL STUDY OF TAL-1 PROTEIN EXPRESSION IN LEUKAEMIAS AND LYMPHOMAS WITH A NOVEL MONOCLONAL ANTIBODY, 2TL 242 1996 ·The Journal of Pathology ·Runjan Chetty, Karen Pulford, Margaret T. Jones, D Mathieu-Mahul, Pauline Close, (unknown), Gorm Pallesen, E. Ralfkiaer, Harald Stein, Kevin C. Gatter, David Y. Mason	7
11	SCL/Tal-1 expression in T-acute lymphoblastic leukemia: An immunohistochemical and genotypic study 1995 ·Human Pathology ·Runjan Chetty, Karen Pulford, Malcolm K. Jones, D Mathieu-Mahul, Pauline Close, (unknown), Gorm Pallesen, E. Ralfkiaer, H. J. Stein, Kevin C. Gatter	12
12	Heterogeneity of CD3 antigen expression in T‐cell lymphoma 1993 ·Histopathology ·Katrina Wood, Gorm Pallesen, E. Ralfkiaer, R Warnke, Kevin C. Gatter, David Y. Mason	12
13	Immunohistological markers for the diagnosis of cutaneous lymphomas. 1991 ·PubMed ·E. Ralfkiaer	55
14	Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen. 1989 ·Journal of Clinical Pathology ·David Y. Mason, J L Cordell, Marion H. Brown, Gorm Pallesen, E. Ralfkiaer, Jonathan B. Rothbard, Michaël J. Crumpton, Kevin C. Gatter	163
15	Aberrant phenotypes in peripheral T cell lymphomas. 1989 ·Journal of Clinical Pathology ·Nina Hastrup, E. Ralfkiaer, Gorm Pallesen	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact